Jan. 2002

●

Founded as MEDRx Co., Ltd

Apr. 2005

●

Became Marketing Authorization Holders for Class I & II pharmaceutical products

Aug. 2005

●

Launch a sales of Iodocoat (R) Ointment 0.9%

Aug. 2007

●

Moving of head office

Oct. 2007

●

Established IL Pharma Inc in USA as a subsidiary

Feb. 2013

●

Llisted on Tokyo Stock Exchange Mothers Index

Apr. 2015

●

Established MEDRx USA INC in USA as a subsidiary

Oct. 2015

●

Merger IL Pharma Inc. and MEDRx USA INC. ,with MEDRx USA as the surviving company

Apr. 2022

●

Transition to the Growth Market of the Tokyo Stock Exchange.

Mar. 2024

●

Established MEDRX AUSTRALIA PTY LTD in Australia as a subsidiary